Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11955-11966
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11955
Table 1 Blood test results of the patient
Parameters
Result of first in hospital (2017)
Result of second in hospital (2021)
Reference range
Hemocyte profile
White blood cell15.52 × 109/L5.3 × 109/L4-10 × 109/L
Hemoglobin157 g/L149 g/L120-160 g/L
Platelet count85 × 109/L30 × 109/L100-300 × 109/L
Neutrophil12.98 × 109/L3.31 × 109/L2-7 × 109/L
Lymphocyte1.49 × 109/L1.53 × 109/L0.8-4.0 × 109/L
Monocyte1.03 × 109/L0.37 × 109/L0.12-0.8 × 109/L
Neutrophil%83.5%62.4%50%-70%
Lymphocyte%9.6%28.9%20%-40%
Eosinophil0.01 × 109/L0.08 × 109/L0.05-0.50 × 109/L
Basophil0.01 × 109/L0.01 × 109/L0.00-0.10 × 109/L
Mean corpuscular volume108.6 fL 113.1 fL80-100 fL
Mean corpuscular hemoglobin36.5 pg38.1 pg27-34 pg
Platelet volume distribution width17.4%16.1%15%-17%
Mean platelet volume12.3 fL10.1 fL7-11 fL
Hypersensitive troponin Ia1.76 ng/mL (0-0.04)0.038 ng/mL (0.01-0.023)
Myoglobina781.5 ng/mL (0-120)48 ng/mL (23-112)
Blood urea nitrogen5.67 mmol/L5.67 mmol/L3.2-7.1 mmol/L
Creatinine91.91 umol/L90.7 umol/L58.0-110.0 umol/L
Thromboelastography
Inhibition rate of AA channel50.4%75.1%≥ 50%, with aspirin
inhibition rate of ADP channel25.9%28.3%≥ 30% with ADP inhibitor
Thrombophilia profile
Prothrombin time10 s10.5 s9.4-12.5 s
Prothrombin activity108%111%70%-140%
International normalized ratio0.930.930.7-1.4
Fibrinogen4.1 g/L3.24 g/L2.00-4.00 g/L
D-dimerNK1.16 ug/mL0.00-0.50 ug/mL
Lipid profile
Total cholesterol8.17 mmol/L5.95 mmol/L3-5.7 mmol/L
Triglycerides2.91 mmol/L2.36 mmol/L< 1.7 mmol/L
HDL cholesterol0.74 mmol/L0.77 mmol/L1.16-1.42 mmol/L
LDL cholesterol6.82 mmol/L4.14 mmol/L< 4.3 mmol/L
Apolipoprotein A0.64 g/L0.88 g/L0.264-1.362 g/L
Apolipoprotein B2.81 g/L1.36 g/L1.05-1.75 g/L